Welcome to the Biotage Sample Preparation Blog

      Biotage


      Recent Posts

      Expansion in San Jose, California, Signifies Next Step for Biotage’s Biologics and Advanced Therapeutics Business

      Sep 14, 2022 3:23:36 PM / by Biotage posted in News

      0 Comments

      Doubling the company’s footprint in Silicon Valley, a hot spot for the promising Biologics and Advanced Therapeutics area, is a testament to Biotage’s commitment and priority to continuously invest and strengthen its presence as a supplier to the Pharma and BioPharma drug discovery and development industry.

      Read More

      Biotage Joins the Swedish GeneNova Collaboration for Gene Therapy Drugs

      Aug 30, 2022 12:52:16 PM / by Biotage

      0 Comments

      Funded by academia, Vinnova and industry, a five-year multi-disciplinary collaboration has been launched to improve efficiency in production methods for adeno-associated virus (AAV) based gene therapies. Biotage is contributing with technology and expertise in plasmid DNA and AAV purification, as well as by funding a dedicated PhD student within the project. “We are thrilled to join the GeneNova project to develop transformative improvements of the drug development and production processes for gene therapies.” says Tomas Blomquist, President and CEO of Biotage.

      Read More

      Biotage launches the Biotage® Selekt  Enkel Flash Purification System

      May 24, 2022 10:54:23 AM / by Biotage

      0 Comments

      Biotage has launched the new Biotage® Selekt Enkel Flash Purification System, a new member of the Selekt family of instruments. Maintaining the small footprint, powerful interface, quality and robustness of the Biotage® Selekt system, the Biotage® Selekt Enkel offers a modular design that allows the system to be modified to meet the demands of your synthesis workflow. The instrument also delivers the greener operation and lower solvent consumption engineered into the Selekt family, making Biotage® Selekt and new Biotage® Selekt Enkel, along with Biotage® Sfär columns, the solutions of choice for those wishing to obtain pure products with minimized environmental impact.

      Read More

      Biotage Launches Extrahera™ HV-5000 High Volume Automated Sample Preparation Workstation

      May 18, 2022 4:05:08 PM / by Biotage posted in Extrahera, hv-5000

      0 Comments

      Biotage has launched the Biotage® Extrahera™ HV-5000, an automated workstation dedicated to column-based sample preparation that is able to aspirate and dispense high volume samples. The system maintains the Extrahera™ family’s small footprint, intuitive software, and precision engineering for the uniform processing of samples. With its 4-channel pipette head, the new workstation is able to aspirate and dispense volumes of 250 – 5000 μL per channel, and offers GLP capability and support for SPE and SLE column formats.

      Read More

      Biotage Annual Report 2021 Released

      Apr 8, 2022 1:25:07 PM / by Biotage posted in annual report

      0 Comments

      Biotage have published their annual report for 2021 giving end of year results for the entire organisation.

      Read More

      Our Ethos: HumanKind Unlimited

      Apr 5, 2022 11:13:07 AM / by Biotage posted in HumanKind Unlimited

      0 Comments

      Biotage is pleased to share its ethos, which captures the essence of the company – HumanKind Unlimited. This reflects Biotage’s commitment to serve the future needs of society, with a focus on the ability of science to unleash the full potential of humanity.

      Read More

      Biotage PhyPrep Automated Plasmid Purification Wins Market Acceptance

      Mar 28, 2022 2:14:42 PM / by Biotage posted in plasmid purification

      0 Comments

      Plasmids are the common starting material for viral vectors, recombinant proteins, mRNA and DNA vaccines. With the rapid growth of interest in cell therapy, gene therapy and advanced therapeutics, the demand for pure DNA plasmids is exponential increasing. However, technological development in this field has lagged behind, and the highly manual plasmid preparation process has remained the same for the last 40 years.

      Read More

      Biotage Chinese Office Celebrates Ten Years

      Mar 14, 2022 2:36:11 PM / by Biotage posted in News

      0 Comments

      The recent global pandemic has illustrated that the development of smarter healthcare is a global need, as acknowledged by the U.N.’s sustainable development program. Biotage has recognized this trend by working to establish itself across multiple geographies, acknowledging that a commitment to HumanKind Unlimited is not restricted by location.

      Read More

      Biotage Acquires ATDBio for DNA and RNA Oligonucleotide Synthesis

      Mar 11, 2022 1:43:29 PM / by Biotage

      0 Comments

      Biotage AB has acquired ATDBio and strengthened its position in DNA and RNA Oligonucleotide synthesis and purification.

      Read More

      Biotage Acquires ATDBio and Strengthens its Position in DNA and RNA Oligonucleotide Synthesis and Purification

      Mar 1, 2022 11:11:02 AM / by Biotage

      0 Comments

      Biotage AB has today entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited  based in Oxford and Southampton, UK. The acquisition of ATDBio adds important platform solutions to Biotage within DNA and RNA oligonucleotide synthesis and purification. This technology is used for applications in drug discovery, molecular diagnostics (such as PCR testing), nucleic acid-based therapeutics and new generation DNA and RNA sequencing technologies.

      Read More